Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) versus Tronox (NYSE:TROX) Head-To-Head Review

Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) and Tronox (NYSE:TROX) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Profitability

This table compares Kiwa Bio-Tech Products Group and Tronox’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kiwa Bio-Tech Products Group	N/A	N/A	N/A
Tronox	-16.22%	-14.75%	-3.83%

Institutional & Insider Ownership

73.4% of Tronox shares are held by institutional investors. 1.3% of Kiwa Bio-Tech Products Group shares are held by company insiders. Comparatively, 2.0% of Tronox shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Kiwa Bio-Tech Products Group and Tronox”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kiwa Bio-Tech Products Group	N/A	N/A	N/A	N/A	N/A
Tronox	$2.90 billion	0.57	-$470.00 million	($2.97)	-3.48

Kiwa Bio-Tech Products Group has higher earnings, but lower revenue than Tronox.

Analyst Recommendations

This is a breakdown of current recommendations for Kiwa Bio-Tech Products Group and Tronox, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kiwa Bio-Tech Products Group	0	0	0	0	0.00
Tronox	3	5	4	0	2.08

Tronox has a consensus price target of $6.55, suggesting a potential downside of 36.62%. Given Tronox’s stronger consensus rating and higher probable upside, analysts clearly believe Tronox is more favorable than Kiwa Bio-Tech Products Group.

Summary

Tronox beats Kiwa Bio-Tech Products Group on 6 of the 9 factors compared between the two stocks.

About Kiwa Bio-Tech Products Group

Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.

About Tronox

Tronox Holdings plc operates as a vertically integrated manufacturer of TiO2 pigment in North America, South and Central America, Europe, the Middle East, Africa, and the Asia Pacific. The company operates titanium-bearing mineral sand mines; and engages in beneficiation and smelting operations. It offers TiO2 pigment; ultrafine specialty TiO2; zircon; feedstock; pig iron; monazite; titanium tetrachloride; and other products. The company’s products are used for the manufacture of paints, coatings, plastics, and paper, as well as various other applications. Tronox Holdings plc is based in Stamford, Connecticut.